MPM Capital

Unique to MPM is an internal team of industry experts that has been specifically assembled not only to enable MPM to assess opportunities but to participate in the value creation and value enhancing acitivites once MPM is an investor. They believe that there senior team is the broadest and deepest team in healthcare venture capital, comprised of talented individuals with impressive investing and finance pedigrees, as well as persons who possess specific functional and operating expertise. MPM executives have and will continue to take interim operating positions in portfolio companies. They can "drop in" expertises in chemistry or biology, intellectual property, licensing and business development, clinical trial design and execution, and commercial operations. Whether we are helping build a company, filling in short-term management gaps, or working alongside management to prepare for key value-creating events, they do whatever it takes to help there companies succeed.

Show more
TypeInvestor
HQCambridge, MA, US
Founded1996
Size (employees)68 (est)
Websitempmcapital.com
Cybersecurity ratingAMore
MPM Capital was founded in 1996 and is headquartered in Cambridge, MA, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at MPM Capital

Patrick A. Baeuerle

Patrick A. Baeuerle

Executive Partner
Christiana Bardon

Christiana Bardon

Managing Director
Thomas M. Barnes

Thomas M. Barnes

Executive Partner
Detlev Biniszkiewicz

Detlev Biniszkiewicz

Executive Partner
Scott Chappel

Scott Chappel

Executive Partner
Stephen Curtis

Stephen Curtis

Managing Director
Show more

MPM Capital Office Locations

MPM Capital has offices in Cambridge and Brisbane
Cambridge, MA, US (HQ)
450 Kendall St
Brisbane, CA, US
2000 Sierra Point Pkwy #701
Show all (2)

MPM Capital Investment Portfolio

Stage Distribution

20002021

Top Sectors Distribution

20022021

Round Size Distribution

20002021
Show more

MPM Capital News and Updates

MPM Capital raises $52.7 mln toward oncology fund

MPM Capital has raised $52.7 million toward a $200 million oncology venture-capital fund, according to a filing with the SEC.

MPM Capital and Versant Ventures Launch CODA Biotherapeutics to Accelerate Development of Chemogenetic Gene Therapy Platform

SOUTH SAN FRANCISCO, Calif., Sept. 12, 2018 /PRNewswire/ -- CODA Biotherapeutics, Inc., a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform for the treatment of intractable diseases, today debuted with a $19 million Series A financing. Lead...

MPM Capital to raise $400 mln venture fund

MPM Capital has set out to raise a $400 million venture fund, according to a filing with the SEC.

MPM Capital expands medical and scientific advisory board with new addition

MPM Capital has added Dr. Stephen J. Elledge to its medical and scientific advisory board. Elledge is a professor at Harvard Medical School.

MPM Capital Online and Social Media Presence

Embed Graph

MPM Capital Frequently Asked Questions

  • When was MPM Capital founded?

    MPM Capital was founded in 1996.

  • Who are MPM Capital key executives?

    MPM Capital's key executives are Patrick A. Baeuerle, Christiana Bardon and Thomas M. Barnes.

  • How many employees does MPM Capital have?

    MPM Capital has 68 employees.

  • Where is MPM Capital headquarters?

    MPM Capital headquarters is located at 450 Kendall St, Cambridge.

  • Where are MPM Capital offices?

    MPM Capital has offices in Cambridge and Brisbane.

  • How many offices does MPM Capital have?

    MPM Capital has 2 offices.